Highly Commended, BMA Medical Book Awards 2013

Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of an acclaimed reference briefs the oncology community with a review of the recent literature, emphasizing the most significant therapeutic advances. The expert contributions of Lung Cancer Therapy Annual 7 offer an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

New to the seventh edition are four new chapters on the treatment of non-small cell lung cancer (NSCLC) and a new chapter on thymoma. Additional topics include:

• Oncogenic driver mutations
• First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
• Second line therapy of non-small cell lung cancer
• Adjunct and neoadjunct therapy of non-small cell lung cancer
• Advances in surgery of lung cancer; advances in radiotherapy of lung cancer
• Mesothelioma
• Thymic tumors